Skip to main content

Basic Evaluation of the Patient with Pelvic Floor Dysfunction (General Review)

  • Chapter
  • First Online:
Female Pelvic Medicine

Abstract

Pelvic floor dysfunction encompasses multiple symptom complexes that can occur alone or in combination. The underlying etiology should be thoroughly elucidated by careful patient history, evaluation of symptoms, and physical examination. Unnecessary tests and procedures should be avoided in the straightforward patient. In complex patients, however, appropriate additional testing is recommended.

Commentary by Eric S. Rovner, Medical University of South Carolina, Department of Urology, Charleston, SC, USA

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Abbreviations

AUA:

American Urological Association

FI:

Fecal incontinence

MMSE:

Mini-mental status exam

MUI:

Mixed urinary incontinence

OAB:

Overactive bladder

PFD:

Pelvic floor dysfunction

PFMT:

Pelvic floor muscle training

POP:

Pelvic organ prolapse

POP-Q:

Pelvic Organ Prolapse Quantification system

PVR:

Post-void residual

SUFU:

Society of Urodynamics, Female Pelvic Medicine and Urogenital Reconstruction

SUI:

Stress urinary incontinence

UTI:

Urinary tract infection

UI:

Urge incontinence

References

  1. Wu JM, Vaughan CP, Goode PS, Redden DT, Burgio KL, Richter HE, Markland AD. Prevalence and trends of symptomatic pelvic floor disorders in U.S. women. Obstet Gynecol. 2014;123(1):141–8.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Herschorn S, Gajewski J, Schulz J, Corcos J. A population-based study of urinary symptoms and incontinence: the Canadian Urinary Bladder Survey. BJU Int. 2008;101(1):52–8.

    PubMed  Google Scholar 

  3. Devore EE, Minassian VA, Grodstein F. Factors associated with persistent urinary incontinence. Am J Obstet Gynecol. 2013;209(2):145.e1–6.

    Article  Google Scholar 

  4. Hu TW, Wagner TH, Bentkover JD, Leblanc K, Zhou SZ, Hunt T. Costs of urinary incontinence and overactive bladder in the United States: a comparative study. Urology. 2004;63(3):461–5.

    Article  PubMed  Google Scholar 

  5. Abrams P, Cardozo L, Fall M, Griffiths D, Rosier P, Ulmsten U, van Kerrebroeck P, Victor A, Wein A. The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society. Am J Obstet Gynecol. 2002;187(1):116–26.

    Article  PubMed  Google Scholar 

  6. Bo K, Frawley HC, Haylen BT, Abramov Y, Almeida FG, Berghmans B, et al. An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for the conservative and nonpharmacological management of female pelvic floor dysfunction. Int Urogynecol J. 2017;28(2):191–213.

    Article  PubMed  Google Scholar 

  7. Sakakibara R, Tateno F, Nagao T, Yamamoto T, Uchiyama T, Yamanishi T, Yano M, Kishi M, Tsuyusaki Y, Aiba Y. Bladder function of patients with Parkinson’s disease. Int J Urol. 2014;21(7):638–46.

    Article  CAS  PubMed  Google Scholar 

  8. Itoh Y, Yamada S, Konoeda F, Koizumi K, Nagata H, Oya M, Suzuki N. Burden of overactive bladder symptom on quality of life in stroke patients. NeurourolUrodyn. 2013;32(5):428–34.

    Google Scholar 

  9. Lykke R, Blaakær J, Ottesen B, Gimbel H. Incidence of pelvic organ prolapse repair subsequent to hysterectomy: a comparison between radical hysterectomy and total abdominal hysterectomy. Int Urogynecol J. 2017;28(5):745–9.

    Article  PubMed  Google Scholar 

  10. Gill EJ, Hurt WG. Pathophysiology of pelvic organ prolapse. Obstet Gynecol Clin North Am. 1998;25(4):757–69.

    Article  CAS  PubMed  Google Scholar 

  11. Lethaby A, Ayeleke RO, Roberts H. Local oestrogen for vaginal atrophy in postmenopausal women. Cochrane Database Syst Rev. 2016;31(8):CD001500.

    Google Scholar 

  12. Loke YK, Singh S. Risk of acute urinary retention associated with inhaled anticholinergics in patients with chronic obstructive lung disease: systematic review. Ther Adv Drug Saf. 2013;4(1):19–26.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  13. Elliott CS, Comiter CV. The effect of angiotensin inhibition on urinary incontinence: data from the National Health and Nutrition Examination Survey (2001–2008). NeurourolUrodyn. 2014;33(8):1178–81.

    Google Scholar 

  14. Twiss C, Triaca V, Rodríguez LV. Familial transmission of urogenital prolapse and incontinence. Curr Opin Obstet Gynecol. 2007;19(5):464–8.

    Article  PubMed  Google Scholar 

  15. Richter HE, Whitehead N, Arya L, Ridgeway B, Allen-Brady K, Norton P, Sung V, Shepherd JP, Komesu Y, Gaddis N, Fraser MO, Tan-Kim J, Meikle S, Page GP, Pelvic Floor Disorders Network. Genetic contributions to urgency urinary incontinence in women. J Urol. 2015;193(6):2020–7.

    Article  PubMed  Google Scholar 

  16. Cartwright R, Kirby AC, Tikkinen KA, Mangera A, Thiagamoorthy G, Rajan P, Pesonen J, Ambrose C, Gonzalez-Maffe J, Bennett P, Palmer T, Walley A, Järvelin MR, Chapple C, Khullar V. Systematic review and metaanalysis of genetic association studies of urinary symptoms and prolapse in women. Am J Obstet Gynecol. 2015;212(2):199.e1–24.

    Article  CAS  Google Scholar 

  17. Lince SL, van Kempen LC, Vierhout ME, Kluivers KB. A systematic review of clinical studies on hereditary factors in pelvic organ prolapse. Int Urogynecol J. 2012;23(10):1327–36.

    Article  PubMed  PubMed Central  Google Scholar 

  18. Rockwood TH, Church JM, Fleshman JW, et al. Fecal incontinence quality of life scale: quality of life instrument for patients with fecal incontinence. Dis Colon Rectum. 2000;43:9.

    Article  CAS  PubMed  Google Scholar 

  19. Rockwood TH, Church JM, Fleshman JW, et al. Patient and surgeon ranking of the severity of symptoms associated with fecal incontinence: the fecal incontinence severity index. Dis Colon Rectum. 1999;42(12):1525–32.

    Article  CAS  PubMed  Google Scholar 

  20. Jorge JMN, Wexner SD. Etiology and management of fecal incontinence. Dis Colon Rectum. 1993;36(1):77–97.

    Article  CAS  PubMed  Google Scholar 

  21. Barber MD, Kuchibhatla MN, Pieper CF, et al. Psychometric evaluation of 2 comprehensive condition-specific quality of life instruments for women with pelvic floor disorders. Am J Obstet Gynecol. 2001;185:1388–95.

    Article  CAS  PubMed  Google Scholar 

  22. Jackson S, Donovan J, Brookers S, et al. The Bristol female lower urinary tract symptoms questionnaire: development and psychometric testing. Br J Urol. 1996;77:805–12.

    Article  CAS  PubMed  Google Scholar 

  23. Avery K, Donovan J, Peters TJ, et al. ICIQ: a brief and robust measure for evaluating the symptoms and impact of urinary incontinence. NeurourolUrodyn. 2004;23:322–30.

    Google Scholar 

  24. Uebersax JS, Wyman JF, Shumaker SA, et al. Short forms to assess life quality and symptom distress for urinary incontinence in women: the Incontinence Impact Questionnaire and the Urogenital Distress Inventory, Continence Program for Women Research Group. NeurourolUrodyn. 1995;14:131–9.

    CAS  Google Scholar 

  25. Wagner TH, Patrick DL, Bavendam TG, et al. Quality of life of persons with urinary incontinence: development of a new measure. Urology. 1996;47:67–71.

    Article  CAS  PubMed  Google Scholar 

  26. Coyne K, Revicki D, Hunt T, et al. Psychometric validation of an overactive bladder symptom and health-related quality of life questionnaire: the OAB-q. Qual Life Res. 2002;11:563–74.

    Article  CAS  PubMed  Google Scholar 

  27. Blaivas JG, Panagopoulos G, Weiss JP, et al. Validation of the overactive bladder symptom score. J Urol. 2007;178:543–7.

    Article  PubMed  Google Scholar 

  28. Bradley CS, Rovner ES, Morgan MA, et al. A new questionnaire for urinary incontinence diagnosis in women: development and testing. Am J Obstet Gynecol. 2005;192:66–73.

    Article  PubMed  Google Scholar 

  29. Stach-Lempinen B, Kujansuu E, Laippala P, et al. Visual analogue scale, urinary incontinence severity score and 15 D: psychometric testing of three different health-related quality-of-life instruments for urinary incontinent women. Scand J Urol Nephrol. 2001;35:476–83.

    Article  CAS  PubMed  Google Scholar 

  30. Krhut J, Zachoval R, Smith PP, Rosier PF, Valanský L, Martan A, Zvara P. Pad weight testing in the evaluation of urinary incontinence. NeurourolUrodyn. 2014;33(5):507–10.

    Google Scholar 

  31. Nitti VW, Mourtzinos A, Brucker BM, SUFU Pad Test Study Group. Correlation of patient perception of pad use with objective degree of incontinence measured by pad test in men with post-prostatectomy incontinence: the SUFU Pad Test Study. J Urol. 2014;192(3):836–42.

    Article  PubMed  Google Scholar 

  32. Groutz A, Blaivas J, Chaikin D, et al. Noninvasive outcome measures of urinary incontinence and lower urinary tract symptoms: a multicenter study of micturition diary and pad tests. J Urol. 2000;164:698–701.

    Article  CAS  PubMed  Google Scholar 

  33. Schick E, Jolivet-Tremblay M, Dupont C, Bertrand PE, Tessier J. Frequency-volume chart: the minimum number of days required to obtain reliable results. NeurourolUrodyn. 2003;22(2):92–6.

    Google Scholar 

  34. Tangalos EG, Smith GE, Ivnik RJ, et al. The Mini-Mental State Examination in general medical practice: clinical utility and acceptance. Mayo Clin Proc. 1996;71(9):829–37.

    Article  CAS  PubMed  Google Scholar 

  35. Dmochowski RR, Blaivas JM, Gormley EA, Juma S, Karram MM, Lightner DJ, Luber KM, Rovner ES, Staskin DR, Winters JC, Appell RA, Female Stress Urinary Incontinence Update Panel of the American Urological Association Education and Research, Inc., Whetter LE. Update of AUA guideline on the surgical management of female stress urinary incontinence. J Urol. 2010;183(5):1906–14.

    Article  PubMed  Google Scholar 

  36. Antovska V. Outcome assessment of the Marshall coughing test during cervix reposition maneuver in women with urinary stress incontinence with/without genital prolapse. ISRN Urol [Internet]. 2012 [cited 2018 Mar 26];2012:109858.

    Google Scholar 

  37. Li C, Gong Y, Wang B. The efficacy of pelvic floor muscle training for pelvic organ prolapse: a systematic review and meta-analysis. Int Urogynecol J. 2016;27(7):981–92.

    Article  PubMed  Google Scholar 

  38. Koh CE, Young CJ, Young JM, Solomon MJ. Systematic review of randomized controlled trials of the effectiveness of biofeedback for pelvic floor dysfunction. Br J Surg. 2008;95(9):1079–87.

    Article  CAS  PubMed  Google Scholar 

  39. Butrick CW. Pathophysiology of pelvic floor hypertonic disorders. Obstet Gynecol Clin North Am. 2009;36(3):699–705.

    Article  PubMed  Google Scholar 

  40. Gormley EA, Lightner DJ, Burgio KL, Chai TC, Clemens JQ, Culkin DJ, Das AK, Foster HE, Scarpero HM, Tessier CD, Vasavada SP, American Urological Association, Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction. Diagnosis and treatment of overactive bladder (non-neurogenic) in adults: AUA/SUFU guideline. J Urol. 2012;188(6 Suppl):2455–63.

    Article  PubMed  Google Scholar 

  41. Gormley EA, Lightner DJ, Faraday M, Vasavada SP, American Urological Association, Society of Urodynamics, Female Pelvic Medicine. Diagnosis and treatment of overactive bladder (non-neurogenic) in adults: AUA/SUFU guideline amendment. J Urol. 2015;193(5):1572–80.

    Article  PubMed  Google Scholar 

  42. Davis R, Jones JS, Barocas DA, Castle EP, Lang EK, Leveillee RJ, et al. Diagnosis, evaluation and follow-up of asymptomatic microhematuria (AMH) in adults: AUA guideline. J Urol. 2012;188(6 Suppl):2473–81.

    Article  PubMed  Google Scholar 

  43. Winters JC, Dmochowski RR, Goldman HB, Herndon CD, Kobashi KC, Kraus SR, Lemack GE, Nitti VW, Rovner ES, Wein AJ, American Urological Association, Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction. Urodynamic studies in adults: AUA/SUFU guideline. J Urol. 2012;188(6 Suppl):2464–72.

    Article  PubMed  Google Scholar 

  44. Staack A, Vitale J, Ragavendra N, Rodríguez LV. Translabial ultrasonography for evaluation of synthetic mesh in the vagina. Urology. 2014;83(1):68–74.

    Article  PubMed  Google Scholar 

  45. Gousse AE, Barbaric ZL, Safir MH, Madjar S, Marumoto AK, Raz S. Dynamic half Fourier acquisition, single shot turbo spin-echo magnetic resonance imaging for evaluating the female pelvis. J Urol. 2000;164(5):1606–13.

    Article  CAS  PubMed  Google Scholar 

  46. Cortes E, Reid WM, Singh K, Berger L. Clinical examination and dynamic magnetic resonance imaging in vaginal vault prolapse. Obstet Gynecol. 2004;103(1):41–6.

    Article  PubMed  Google Scholar 

  47. Turner-Warwick R, Whiteside CG, Worth PH, Milroy EJ, Bates CP. A urodynamic view of the clinical problems associated with bladder neck dysfunction and its treatment by endoscopic incision and trans-trigonal posterior prostatectomy. Br J Urol. 1973;45:44–59.

    Google Scholar 

  48. Nager C, Brubaker L, Litman H, et al. A randomized trial of urodynamic testing before stress-incontinence surgery. NEJM. 2012;366:1987–97.

    Google Scholar 

  49. Dmochowski RR, Blaivas JM, Gormley EA, Juma S, Karram MM, Lightner DJ, Luber KM, Rovner ES, Staskin DR, Winters JC, Appell RA. Female stress urinary incontinence update panel of the American Urological Association Education and Research, Inc., Whetter LE. Update of AUA guideline on the surgical management of female stress urinary incontinence. J Urol. 2010;183(5):1906–14.

    Google Scholar 

  50. Kobashi KC, Albo ME, Dmochowski RR, et al. Surgical treatment of female stress urinary incontinence (SUI): AUA/SUFU guideline: published 2017. 2017. https://www.auanet.org/guidelines/incontinence-stress-urinary-incontinence.

  51. Gormley EA, Lightner DJ, Burgio KL, Chai TC, Clemens JQ, Culkin DJ, Das AK, Foster HE, Scarpero HM, Tessier CD, Vasavada SP, American Urological Association, Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction. Diagnosis and treatment of overactive bladder (non-neurogenic) in adults: AUA/SUFU guideline. J Urol. 2012;188(6 Suppl):2455–63.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Raveen Syan .

Editor information

Editors and Affiliations

Commentary

Commentary

This is an excellent chapter describing the initial evaluation of the patient with pelvic floor dysfunction. These authors provide a comprehensive description and rationale for the salient components of a good history, physical examination, and other preliminary lines of inquiry (e.g., questionnaires and diaries) which provide a basis for the initial diagnosis and interventional planning in most patients presenting with pelvic floor dysfunction. The importance of these components, especially taking a good history and doing a complete physical examination, when done well, cannot be overemphasized. It is easy to overlook the value and expertise required to do these most basic components of the patient intake process well. These skills were initially acquired as medical students and then developed as interns and residents in training and then continuously refined as active practitioners. To this end, the astute clinician practices, retains, and exploits these proficiencies on a daily basis and does not permit the “templating” and “box checking” of the modern electronic medical record to supplant this acquired expertise.

Patients with pelvic floor dysfunction represent a broad array of connected pathologies. As the authors point out, symptoms in one system or compartment (i.e., urinary) should lead to an exploration and solicitation of other potentially related symptoms and signs (defecatory, sexual, etc.). Although, as clinicians, we are acutely aware of the intimate relationship between the various domains of the pelvic floor, the patient may not realize that these disorders are very often connected and may not offer their full array of complaints unless directly queried. Such patients are often quite relieved when they are counseled that their seemingly disparate symptoms are related and can be addressed simultaneously in a well-constructed therapeutic plan.

The bladder has been historically and famously termed an “unreliable witness” for many reasons including the limitations of patient recall of symptoms, as well as a lack of exact correlation of individual symptoms to a definitive diagnosis [47]. This characterization has been historically utilized as justification to pursue invasive diagnostic testing such as urodynamics in many patients. However, the wise clinician can elicit relevant symptoms, signs, and physical examination findings, parse through these data, and often arrive at a provisional and even definitive diagnosis prior to pursuing additional testing in the majority of patients with pelvic floor dysfunction, thus avoiding the cost and inconvenience of such investigations. In fact, recent publications have questioned the widespread utility of urodynamics in particular even when contemplating surgery [48].

In an era of buzzwords including cost containment, and quality of care, a thorough “H and P” can preclude the need for invasive and expensive tests such urodynamics or imaging in many, if not most, uncomplicated cases. Recently published guidelines certainly support such an approach [49,50,51]. Though the pace of advanced technological innovation in the diagnosis of pelvic floor disorders and indeed in all of medicine is accelerating, and the momentum is sometimes difficult to resist, such investigations are only variably and infrequently indicated when a proper, well-done, and complete initial evaluation is performed. This is not to suggest that such testing is unnecessary, but rather it should be selectively utilized, always balancing the incremental information gleaned from these investigations with the cost, invasiveness, and discomfort resulting from their utilization. It is appropriately emphasized by these authors that additional invasive testing should be reserved for those patients who remain complex diagnostic dilemmas following a thorough initial evaluation and/or obtained in those patients in whom irreversible, invasive, and expensive interventions are being pursued (e.g., surgery) and further or definitive diagnostic clarity is necessary.

Rights and permissions

Reprints and permissions

Copyright information

© 2021 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Syan, R., Enemchukwu, E.A., Dobberfuhl, A.D., Comiter, C.V. (2021). Basic Evaluation of the Patient with Pelvic Floor Dysfunction (General Review). In: Kobashi, K.C., Wexner, S.D. (eds) Female Pelvic Medicine. Springer, Cham. https://doi.org/10.1007/978-3-030-54839-1_1

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-54839-1_1

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-54838-4

  • Online ISBN: 978-3-030-54839-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics